521MO Efficacy of pembrolizumab monotherapy (PM) for advanced clear cell gynaecological cancer (CCGC): Phase II PEACOCC trial
Rebecca Kristeleit, Andrew R. Clamp, C. Gourley, René L. Roux, Marcia Hall, M-J. Devlin, Rachel Nirsimloo, Valentinos Kounnis, Lucy Hughes, Nicholas Counsell, Laura Farrelly, Robert F. Miller
Topics & Concepts
MedicineInternal medicineClinical endpointPembrolizumabAdverse effectProgression-free survivalGastroenterologyPhases of clinical researchOncologyChemotherapyClinical trialSurgeryCancerImmunotherapyOvarian cancer diagnosis and treatmentLymphoma Diagnosis and TreatmentEndometrial and Cervical Cancer Treatments